glutaurine

recently deteccted hormone of parathyroid gland; structure; RN given refers to (L)-isomer

Also Known As:

Litoralon; alpha-glutamyl taurine; alpha-glutamyltaurine; gamma-L-glutamyl-taurine; gamma-L-glutamyltaurine; glautaurine; glutaurin; glutaurin, (D)-isomer; N-(2- sulfoethyl)-L-glutamine

Networked: 9 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 01/01/1983 - "Glutaurine significantly decreased the incidence of hepatoma, but had no significant effect on the lethality of MC29/L infected birds. " 01/01/1983 - "The effect of glutaurine (gamma-L-glutamyl-taurine, Litoralon) on the take and development of hepatoma and acute leukaemia induced by MC29/L avian oncorna-virus has been investigated in turkey poults. "
2.	Amnesia (Dissociative Amnesia) 08/01/1988 - "When the treatment with glutaurine was applied immediately after the electroconvulsive shock, even 1 and 10 micrograms doses were effective in attenuating the amnesia in both the 24h and 48h retestings. " 08/01/1988 - "The data indicate that glutaurine is able to prevent electroconvulsive shock-induced amnesia by counteracting the effect of the electroconvulsive shock on the memory consolidation phase, but it is less effective on learning or it is ineffective on retrieval processes." 08/01/1988 - "Oral treatment with glutaurine in a dose of 1-20 micrograms was ineffective on electroshock-induced amnesia if the treatment was applied before the electroconvulsive shock. " 08/01/1988 - "Effects of glutaurine treatment on electroshock-induced amnesia. " 08/01/1988 - "The effects of oral glutaurine (gamma-L-glutamyl-taurine, LitoralonR Chinoin, Budapest) treatment on electroconvulsive shock-induced amnesia were studied. "
3.	Neoplasms (Cancer) 10/01/1983 - "It is suggested that glutaurine increases the originally low spontaneous killer activity of tumor patients' lymphocytes through an indirect regulatory mechanism." 10/01/1983 - "Both in vivo and in vitro treatment with glutaurine markedly enhanced the depressed natural lymphocytotoxicity of tumor patients without influencing their lymphocyte subpopulations. " 10/01/1983 - "Glutaurine enhances the depressed NK cell activity of tumor patients." 01/01/1981 - "A marked increase in "K" cell activity was observed in 8 tumor patients with originally low cytotoxic capacity, while originally normal ADCC activity of other tumor patients and healthy subjects was not significantly influenced by glutaurine treatment. " 09/02/1984 - "[Effect of Litoralon therapy on the lymphocytotoxicity in patients with malignant tumors]."
4.	Body Weight (Weight, Body) 01/01/1986 - "Correlative changes in the protein contents of haemolymph and fat body and the accumulation of protein storage granules in the fat body cells of Mamestra brassicae were investigated during the last larval stage in normally developing larvae and following administration of glutaurine (1 X 10(-4) mg/g body weight). " 06/01/1980 - "In case of the daily administration of 20 mg BAPN + 0.2 mg extract P/100 g body weight and of 40 mg BAPN + 0.2 micrograms glutaurine/100 g body weight, both substances were found to attenuate the manifestations of osteolathyrism, to a significant extent, without, however preventing their development completely. "
5.	Disease Progression 01/01/1986 - "Glutaurine exerts moderate immunostimulating activity, but fails to influence the clinical course of systemic lupus erythematosus. "

Related Drugs and Biologics

1.	glutaurine
2.	Proteins (Proteins, Gene)
3.	Parathyroid Hormone (Parathormone)
4.	Aminopropionitrile

Related Therapies and Procedures

1.	Therapeutics